• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Methods Protoc . Inactivation of Material from SARS-CoV-2-Infected Primary Airway Epithelial Cell Cultures

tetano

Editor, Senior Moderator
Methods Protoc


. 2021 Jan 7;4(1):E7.
doi: 10.3390/mps4010007.
Inactivation of Material from SARS-CoV-2-Infected Primary Airway Epithelial Cell Cultures


Kaitlyn A Barrow[SUP] 1 [/SUP], Lucille M Rich[SUP] 1 [/SUP], Elizabeth R Vanderwall[SUP] 1 [/SUP], Stephen R Reeves[SUP] 1 2 [/SUP], Jennifer A Rathe[SUP] 3 [/SUP], Maria P White[SUP] 1 [/SUP], Jason S Debley[SUP] 1 2 [/SUP]



Affiliations

Abstract

Given that the airway epithelium is the initial site of infection, study of primary human airway epithelial cells (AEC) infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will be crucial to improved understanding of viral entry factors and innate immune responses to the virus. Centers for Disease Control and Prevention (CDC) guidance recommends work with live SARS-CoV-2 in cell culture be conducted in a Biosafety Level 3 (BSL-3) laboratory. To facilitate downstream assays of materials from experiments there is a need for validated protocols for SARS-CoV-2 inactivation to facilitate safe transfer of material out of a BSL-3 laboratory. We propagated stocks of SARS-CoV-2, then evaluated the effectiveness of heat (65 ?C) or ultraviolet (UV) light inactivation. We infected differentiated human primary AECs with SARS-CoV-2, then tested protocols designed to inactivate SARS-CoV-2 in supernatant, protein isolate, RNA, and cells fixed for immunohistochemistry by exposing Vero E6 cells to materials isolated/treated using these protocols. Heating to 65 ?C for 10 min or exposing to UV light fully inactivated SARS-CoV-2. Furthermore, we found in SARS-CoV-2-infected primary AEC cultures that treatment of supernatant with UV light, isolation of RNA with Trizol[SUP]?[/SUP], isolation of protein using a protocol including sodium dodecyl sulfate (SDS) 0.1% and Triton X100 1%, and fixation of AECs using 10% formalin and Triton X100 1%, each fully inactivated SARS-CoV-2.

Keywords: COVID-19; RNA; SARS-CoV-2; Vero E6; airway; epithelial; heat; inactivation; protein.
 
Back
Top Bottom